In contrast, interleukins like IL-4, IL-5, IL-10, and IL-13, which contribute to the chronic inflammatory protumorigenic response, promote tumor progression and immune evasion through their interactions with the tumor microenvironment. This evidence concerns the gene IL4 and neoplasm.